Harrow, Inc. (NASDAQ:HROW) Q4 2024 – Earnings Conference Call March 28, 2025 8:00 AM ET
Company Participants
Jamie Webb – Director, Communications & IR
Mark Baum – CEO
Andrew Boll – CFO
Conference Call Participants
Chase Knickerbocker – Craig Hallum
Thomas Flaten – Lake Street Capital Markets
Jeffrey Cohen – Ladenburg Thalmann and Company
Mayank Mamtani – B. Riley Securities
Yi Chen – H. C. Wainwright
Operator
Good morning, and welcome to Harrow’s Fourth Quarter and Year End 2024 Earnings Conference Call. My name is Gigi, and I’ll be your operator for today’s call. At this time, all participants are in a listen only mode. Later, we will conduct a question and answer session. As a reminder, this conference is being recorded.
I would now like to turn the call over to Jamie Webb, Director of Communications and IR for Harrow.
Jamie Webb
Thank you, operator. Good morning, and welcome to Harrow’s fourth quarter and year end 2024 earnings conference call. Before we begin today, let me remind you that the company’s remarks may include forward-looking statements within the meaning of federal securities laws. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond Harrow’s control, including risks and uncertainties described from time to time in its SEC filings, such as the risk and uncertainties related to the company’s ability to make commercially available its FDA approved products and compounded formulations and technologies and FDA approval of certain drug candidates in a timely manner or at all. For a list and description of those risks and uncertainties, please see the risk factors section of the company’s most recent annual report on Form 10k and subsequent quarterly reports on Form 10Q filed with the Securities and Exchange Commission.
Results may differ materially from those projected. Harrow disclaims any
Read the full article here